Clinical Trials
7 trialsNCT05895994 2026-02-03
Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiation 7(CD7)-Positive Hematological Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1 Completed
NCT05923541 2024-11-22
RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies
Henan Cancer Hospital
Phase EARLY_PHASE1 Completed
NCT05716113 2024-11-21
CD7 CAR-T for Patients With r/r CD7+ T-ALL/T-LBL
Zhejiang University
Phase EARLY_PHASE1 Completed
NCT05902845 2024-11-21
RD13-02 CAR-T Cell Injection for Patients With r/r CD7+ T-ALL/T-LBL
Anhui Provincial Hospital
Phase EARLY_PHASE1 Completed
NCT05907603 2024-11-21
Research Development（RD）13-02 Chimeric Antigen Receptor(CAR) -T Cell Injection for Patients With r/r Cluster Of Differentiation 7（CD7）+ T-Acute Lymphoblastic Leukemia(ALL)/T-Lymphoblastic Lymphoma(LBL) /Acute Myelogenous Leukemia(AML)
Xuzhou Medical University
Phase EARLY_PHASE1 Completed
NCT04742595 2024-10-29
Viral Specific T Cell Therapy for COVID-19 Related Pneumonia
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT00896792 2018-10-09
Nurse Practitioner Hospice Program for Patients With Terminal Metastatic Cancer and Their Families or Caregivers
Mayo Clinic
Phase EARLY_PHASE1 Completed